Method for preparing recombinant adeno-associated virus
A method for producing recombinant adeno-associated virus, the method including: (1) transforming a gene of interest (GOI) into a recombinant baculovirus, where the recombinant baculovirus has a genome integrated with AAV Rep gene, Cap gene, and rAAV genome ITR-GOI that are needed in the production of the rAAV; and where the ITR-GOI is linked to expression cassette of the Cap gene and the Rep gene by a 5′ terminal nucleic acid segment or a 3′ terminal nucleic acid segment; (2) infecting host insect larvae with the recombinant baculovirus prepared in (1), such that the rAAV is produced in vivo in the host insect larvae; and (3) lysing the host insect larvae obtained in (2), and extracting and purifying the rAAV.
1. A method for producing recombinant adeno-associated virus, the method comprising:
(1) transforming a gene of interest (GOI) into a recombinant baculovirus, wherein the recombinant baculovirus has a genome integrated with AAV Rep gene, Cap gene, and rAAV genome ITR-GOI; and the ITR-GOI is linked to expression cassette of the Cap gene and the Rep gene by a 5′ terminal nucleic acid segment or a 3′ terminal nucleic acid segment of the ITR-GOI; and the 5′ terminal nucleic acid segment or the 3′ terminal nucleic acid segment is a ligation nucleic acid sequence having a length ranging from 80 to 140 bp;
(2) infecting host insect larvae with the recombinant baculovirus prepared in (1) to produce the rAAV in vivo in the host insect larvae; and
(3) lysing the host insect larvae obtained in (2), and extracting and purifying the rAAV,
wherein the infecting host insect larvae with the recombinant baculovirus prepared in (1) to produce the rAAV in vivo in the host insect larvae comprises:
(2-1-1): feeding hatched host insect larvae to between a 4th instar stage and a 5th instar stage;
(2-1-2): inoculating the host insect larvae obtained in (2-1-1) by subcutaneously injecting 10-20 μL, of the recombinant baculovirus at a titer of 1×10 7 VG/mL to 1×10 9 VG/mL prepared in (1); and
(2-1-3): feeding the host insect larvae injected with the recombinant baculovirus obtained in (2-1-2) until the larvae have the symptoms of appetite loss, sluggish movement, and swollen somite, and then stopping feeding, and harvesting the larvae.
2. The method of claim 1 , wherein in (2-1-3), the feeding is stopped when the symptoms occur in 3 to 7 days after the host insect larvae are infected with the recombinant baculovirus.
3. The method of claim 1 , wherein the recombinant baculovirus includes part of genome sequence of Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) (Genbank accession No.: KM667940.1 or NC_001623.1) or Bombyx mori nucleopolyhedrovirus (BmNPV) (Genbank accession No.: L33180.1).
4. The method of claim 1 , wherein the host insect larvae are larvae of beet armyworm or silkworm.
5. The method of claim 1 , wherein in (3), the lysing of the host insect larvae comprises: mashing and grinding the host insect larvae, adding a PBS solution, homogenizing, freezing, and then thawing, to prepare the lysate.
6. The method of claim 1 , wherein in (3), the step of extracting and purifying the rAAV comprises: centrifuging the lysate after the host insect larvae is lysed, collecting the supernatant, and extracting with chloroform, to obtain a preliminarily purified rAAV.